Biopharm Co. Stockholders Challenge Director Pay In Del. Suit

By Leslie A. Pappas (November 29, 2022, 8:50 PM EST) -- A stockholder of gene therapy company Adverum Biotechnologies Inc. has sued its current and past directors on Adverum's behalf in Delaware's Court of Chancery, seeking to recover allegedly "grossly excessive" compensation that the company had paid to board members....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!